Desktop Site
|
25 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
74,339.44
+486.50
+0.66 %
Corporate Announcement
Security Code
539524
Company
Dr. Lal PathLabs Ltd
Exchange Disseminated Time
Board to consider Q2 results & Interim Dividend on Nov 09, 2017 |
9/29/2017 12:18:21 PM
Dr. Lal PathLabs Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on November 09, 2017, inter alia, to consider and approve the un-audited financial results of the Company for the Quarter & Half Year ended September 30, 2017 and to consider the proposal of payment of interim dividend, if any, for the Financial Year 2017-18.
Further, the Trading Window, as per the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s code for Prevention of Insider Trading, will be closed from October 01, 2017 till November 11, 2017 for the purpose of announcement / declaration of such results by the Company.
<< Back
Recently Viewed